MK-7075 (Miransertib) in Proteus Syndrome
MK-7075 (Miransertib) in Proteus Syndrome
Active, not recruiting · NCT04316546 · Registry updated 2026-07-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MK-7075 (Miransertib) in Proteus Syndrome | Abnormalities, Multiple, Bone Diseases, Developmental, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cowden disease, Limb Deformities, Congenital, Musculoskeletal Abnormalities, Neoplasms, Multiple Primary, Proteus syndrome, bone disorder, hamartoma, musculoskeletal system disorder, neoplasm | Active, not recruiting | Phase 2 | 2026-07-17 | NCT04316546 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Human Genome Research Institute (NHGRI) | 54 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | United States | 800 |